Trial of Lymphoseek in Intraoperative Localization of Lymph Nodes in Breast Cancer and Melanoma
Public ClinicalTrials.gov record NCT00671918. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Phase 3, Prospective, Open-Label, Multicenter Comparison Study of Lymphoseek® and Vital Blue Dye as Lymphoid Tissue Targeting Agents in Patients With Known Melanoma or Breast Cancer Who Are Undergoing Lymph Node Mapping
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
Data from this pivotal clinical trial will be used to support a marketing application (i.e., NDA) for Navidea's Lymphoseek for use in intraoperative localization of lymph tissue (nodes) in the lymphatic pathway draining the primary site of a tumor.
Study identification
- NCT ID
- NCT00671918
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 186 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2008 (Type not available)
- Primary completion
- Jun 2009 (Actual)
- Completion
- Jul 2009 (Actual)
- Last update posted
- Jun 17, 2013
2008 – 2009
United States locations
- U.S. sites
- 14
- U.S. states
- 5
- U.S. cities
- 12
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Barbara Michna, M.D | Alexander City | Alabama | 35010 | — |
| Helen Krontiras, M.D. | Birmingham | Alabama | 35294 | — |
| Anne Wallace, M.D. | La Jolla | California | 92093 | — |
| Ken Deck, M.D. | Laguna Hills | California | 92653 | — |
| Steve Martinez, M.D. | Sacramento | California | 95817 | — |
| Mark Faries, M.D. | Santa Monica | California | 90404 | — |
| Eli Avisar, M.D. | Miami | Florida | 33101 | — |
| Charles Cox, M.D. | Tampa | Florida | 33612 | — |
| Vernon Sondak, M.D. | Tampa | Florida | 33612 | — |
| Julian Kim, M.D. | Cleveland | Ohio | 44106 | — |
| Bruce Averbook, M.D | Cleveland | Ohio | 44109 | — |
| Stephen Povoski, M.D. | Columbus | Ohio | 43210 | — |
| Thomas Frazier, M.D. | Bryn Mawr | Pennsylvania | 19010 | — |
| Ned Carp, M.D. | Philadelphia | Pennsylvania | 19096 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 1 non-U.S. site.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00671918, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Jun 17, 2013 · Synced Oct 17, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00671918 live on ClinicalTrials.gov.